SymBio Pharmaceuticals Limited reported non consolidated earnings results for the first quarter ended March 31, 2012. For the period, the company reported net sales were JPY 580 million against JPY 348 million a year ago. Operating loss was JPY 480 million against JPY 410 million a year ago. Ordinary loss was JPY 515 million against JPY 392 million a year ago. Net loss was JPY 516 million or JPY 27.00 per share against JPY 399 million or JPY 3,224.54 per share a year ago. Loss before tax was JPY 398.126 million against JPY 515.508 million a year ago. For the full year of 2012, the company expects net sales to be JPY 2,338 million, operating loss to be JPY 1,625 million, ordinary loss to be JPY 1,652 million and net loss to be JPY 1,656 million or JPY 86.56 per share.